Medical News

RSS

Novartis closes acquisition with Nestlé from remaining stake in Alcon

The Alcon Independent Director Committee notes the closing of Novartis AG's acquisition of Nestlé SA's remaining stake in Alcon, Inc.

26 Aug 2010

Battle for public opinion of health overhaul continues in states

The (Portland) Oregonian: Health and Human Services Secretary Kathleen Sebelius visited Oregon Tuesday, where state officials -- unlike their counterparts in many capitals around the country -- broadly back the health overhaul plan. "Sebelius is reaching out to governors and state officials, whose cooperation is crucial in implementing the federal health reform law passed in March. The law makes states responsible for accomplishing much of the overhaul work."

26 Aug 2010

Stryker Corporation announces definitive agreement to acquire Gaymar Industries

Stryker Corporation announced today a definitive agreement to acquire privately held Gaymar Industries. Under the terms of the agreement, Stryker will acquire Gaymar Industries for approximately $150 million in an all-cash transaction.

From Stryker 26 Aug 2010

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.

26 Aug 2010

IMA receives five-year renewal grant from National Science Foundation

The University of Minnesota's Institute for Mathematics and its Applications (IMA) has been awarded a $20.5-million National Science Foundation (NSF) renewal grant over the next five years. The renewal grant continues the IMA's tradition as one of the nation's top math institutes in terms of funding.

26 Aug 2010

3D MRI enhances visualization, displays fetal anatomy and diagnosing problems

Three-dimensional MRI is an emerging and useful technique for displaying fetal anatomy and diagnosing problems in the womb in a wide spectrum of clinical applications, according to Jeffrey C. Hellinger, M.D., a pediatric imaging specialist at Stony Brook University Medical Center.

26 Aug 2010

Research finds adenovirus impact on cell's suicide program pave way for new cancer therapy

A novel mechanism used by adenovirus to sidestep the cell's suicide program, could go a long way to explain how tumor suppressor genes are silenced in tumor cells and pave the way for a new type of targeted cancer therapy, report researchers at the Salk Institute for Biological Studies in the Aug. 26, 2010 issue of Nature.

26 Aug 2010

Advaxis' 'Prokaryotic peptides for enhancing antigen immunogenicity' European patent application allowed

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has been notified by the European Patent Office that patent application WO2001/072329, for the use of Prokaryotic PEST-Like Peptides for Enhancing Immunogenicity of Antigen has been allowed for issuance. This patent will be #1,303,299 when granted, and will be licensed exclusively to Advaxis by the University of Pennsylvania.

26 Aug 2010

Researchers to test new plantain based food product to treat Crohn's disease

Crohn's is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea. Researchers are working with biotechnology company, Provexis, to test a new plantain based food product that could treat patients with the disease.

26 Aug 2010

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.

26 Aug 2010

Device firms skid as health IT looks to bright future

As companies look forward to a bright future in some areas of health technology--namely, electronic medical records--other parts of the med-tech industry are watching sales slip.

26 Aug 2010

Researchers prove iPS cells can help to treat liver diseases

Great excitement greeted the discovery a few years ago that certain cells from mice and humans could be reprogrammed to become inducible pluripotent stem cells (iPS cells), as they hold promise for cell replacement therapy and modeling human disease.

26 Aug 2010

Verizon and Nebraska Domestic Violence Sexual Assault Coalition enter new partnership to end domestic violence

Nebraska domestic violence prevention advocates will learn how to use the latest technology to help keep abuse survivors safe, thanks to a new partnership between the Nebraska Domestic Violence Sexual Assault Coalition (NDVSAC) and Verizon.

26 Aug 2010

HEALTHeCAREERS grants $15,000 scholarship to radiologic science graduates

HEALTHeCAREERS Network helps fund these scholarships that are administered by the charitable arm of the American Society of Radiologic Technologists (ASRT). The association's $15,000 scholarship total is divided into $1,500 awards that are given to undergraduate or graduate students completing a degree in radiologic sciences.

26 Aug 2010

Early intervention is key to proper healing of foot pain due to sports activities

According to Donna's doctor, Kris DiNucci, DPM, FACFAS, a Fellow of the American College of Foot and Ankle Surgeons, the conditions plaguing her are common among court-playing athletes. "Because playing tennis requires quick, repetitive foot movements and continuous forefoot pressure, neuromas, (a thickening of the nerve tissue in the foot from compression) are common," DiNucci says. "In addition, those same movements can cause athletes to develop plantar fasciitis, an inflammation of the strong ligament that extends from the heel to the toes," he added.

26 Aug 2010

ACT comments on federal fund blocking for embryonic stem cell research

Advanced Cell Technology, Inc. commented today on yesterday's federal court ruling, temporarily blocking federal funding for embryonic stem cell research involving the destruction of embryos.

26 Aug 2010

Europe's pharma sector faces increasing challenges

The Wall Street Journal: "After a healthy second quarter, Europe's pharmaceutical sector may find itself in trouble in the months ahead as companies face patent expiries, tougher regulation and burdensome health care reforms.

26 Aug 2010

Biogen to publish data on two-step assay for anti-JC virus antibody detection

Biogen Idec and Elan Corporation, plc today announced data has been published in the Annals of Neurology on an investigational, two-step assay to detect anti-JC virus (JCV) antibodies in human serum and plasma

26 Aug 2010

Cyberonics reports 16% increase in net sales for first quarter 2011

Cyberonics, Inc. today announced results for the quarter ended July 30, 2010.

26 Aug 2010

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.

26 Aug 2010